ongitudinal assessment of therapy-related early ageing in adolescent and young adult (AYA) cancer patients

Recruiting

• Conditions: (non-)Hodgkin lymphoma; and cervical cancer; breast cancer; cancer: including leukemia; Ewing sarcoma; osteosarcoma; testicular cancer; 10027655

• Registration Number: NL-OMON49923
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

- Aged 18-39 years at cancer diagnosis
- Having a histologically and/or cytologically confirmed cancer diagnosis,
including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma,
Ewing sarcoma, breast cancer, and cervical cancer.
- Scheduled to start systemic therapy with curative intent. Allowed treatments
(concurrent or sequential) are: surgery, radiotherapy, chemotherapy,
antibodies.

Exclusion Criteria

- who are not able to understand the patient information letter and informed
consent form
- who will be treated with immune checkpoint inhibitors or targeted therapy
with inhibitors of angiogenesis
- who have been treated with systemic therapy or radiotherapy for a previous
malignancy (exceptions: in situ carcinoma of the cervix or uterus and
adequately treated basal and squamous cell carcinoma of the skin).

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified